The Mre 11 complex (Mrel 1, Rad50, and Nbsl) plays a central role in governing the cellular response to DNA damage and maintaining genomic stability. The diverse functions of the complex include the sensing of DNA damage, regulation of cell cycle checkpoints, and telomere maintenance. Mutations in the Nbsl and Mrel 1 genes cause the human diseases Nijmegen Breakage Syndrome (NBS) and Ataxia-telangiectasia like disease (A-TLD) which result in clastogen sensitivity and cancer predisposition. The role of the Mrel 1 complex in telomere metabolism and the status of these functions in NBS and A-TLD remain largely unexplored. I propose to use mouse models of NBS and A-TLD to examine the impact of Mre11 complex deficiency on telomere maintenance, and cancer development. I will 1) characterize the effects of Mre11 complex deficiency on telomere status, 2) determine the impact of Mrel I complex deficiency on the response telomere dysfunction and 3) analyze the genetic interactions of the Mre11 complex and determine their impact on telomere metabolism and the development of malignancy.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM072469-02
Application #
6942283
Study Section
Special Emphasis Panel (ZRG1-F08 (20))
Program Officer
Tompkins, Laurie
Project Start
2004-09-01
Project End
2006-02-28
Budget Start
2005-09-01
Budget End
2006-02-28
Support Year
2
Fiscal Year
2005
Total Cost
$24,148
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065